The Lancet Oncology in conversation with

By The Lancet Group

Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

... more

5

11 ratings

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about The Lancet Oncology in conversation with:

How many episodes does The Lancet Oncology in conversation with have?

The podcast currently has 212 episodes available.

The Lancet Oncology in conversation with episodes:

January 21, 2021 Sathira Perera on global cancer surgery
Sathira Perera (University of New South Wales, Australia) discusses his (and colleagues) Articles on the global use of cancer surgery.

Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30675-6/fulltext
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
8min
January 04, 2021 Short-course radiotherapy for advanced rectal cancer
Geke Hospers (University Medical Center Groningen, The Netherlands) discusses the RAPIDO trial Article published in The Lancet Oncology.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
7min
November 16, 2020 The crucial role of oncology nurses in cancer care
Annie Young (University of Warwick, UK) and Julia Challinor (University of California San Francisco, USA) present their two-paper Series on Oncology Nursing.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
27min
November 02, 2020 The effect of climate change on cancer control
Robert Hiatt (University of California San Francisco, USA) discusses his and Naomi Beyeler’s (same University) Review on climate change and cancer.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
12min
September 29, 2020 Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer
Paul Sargos (Institut Bergonié, France) discusses the GETUG-AFU 17 trial and Andrew Kneebone (Royal North Shore Hospital and University of Sidney, Australia) the RAVES trial.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
17min
September 05, 2020 Peptide receptor radionuclide therapy for neuroendocrine tumours
Lisa Bodei (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses the Review in The Lancet Oncology on molecular profiling of neuroendocrine tumours to predict response to peptide receptor radionuclide therapy.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
20min
April 07, 2020 Larotrectinib in patients with TRK fusion-positive solid tumours
Alexander Drilon (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a pooled analysis in The Lancet Oncology on the role of larotrectinib in patients with TRK fusion-positive solid tumours.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
14min
March 11, 2020 The future of radiotheranostics
Ken Herrman (University Hospital Essen, Essen, Germany) discusses a Review in The Lancet Oncology on the role of injectable radiopharmaceuticals with anti-tumour effects.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
8min
March 03, 2020 International standards for the analysis of patient-reported outcomes in cancer trials
Corneel Coens and Madeline Pe discuss recommendations from the SISAQOL Consortium for the analysis of patient-reported outcomes, published in a Policy Review in The Lancet Oncology.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
12min
January 09, 2020 Presenting symptoms of cancer and stage at diagnosis
Monica Koo (University College London, London, UK) discusses an Article in The Lancet Oncology on presenting symptoms of cancer and stage at diagnosis in patients in England.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
...more
7min

FAQs about The Lancet Oncology in conversation with:

How many episodes does The Lancet Oncology in conversation with have?

The podcast currently has 212 episodes available.

More shows like The Lancet Oncology in conversation with

Nature Podcast by Springer Nature Limited

Nature Podcast

756 Listeners

Science Magazine Podcast by Science Magazine

Science Magazine Podcast

811 Listeners

JAMA Editors' Summary by JAMA Network

JAMA Editors' Summary

131 Listeners

NEJM This Week by NEJM Group

NEJM This Week

325 Listeners

Journal of Clinical Oncology (JCO) Podcast by American Society of Clinical Oncology (ASCO)

Journal of Clinical Oncology (JCO) Podcast

38 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

493 Listeners

ASCO Daily News by American Society of Clinical Oncology (ASCO)

ASCO Daily News

58 Listeners

JAMA Medical News by JAMA Network

JAMA Medical News

90 Listeners

Core IM | Internal Medicine Podcast by Core IM Team

Core IM | Internal Medicine Podcast

1,095 Listeners

ASCO Guidelines by American Society of Clinical Oncology (ASCO)

ASCO Guidelines

43 Listeners

The Readout Loud by STAT

The Readout Loud

318 Listeners

Annals On Call Podcast by American College of Physicians

Annals On Call Podcast

185 Listeners

Think Fast Talk Smart: Communication Techniques by Matt Abrahams, Think Fast Talk Smart

Think Fast Talk Smart: Communication Techniques

794 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

23 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

2 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

1 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Healthy Longevity in conversation with by The Lancet Group

The Lancet Healthy Longevity in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

eClinicalMedicine in conversation with by The Lancet Group

eClinicalMedicine in conversation with

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

Two Onc Docs by Sam and Karine

Two Onc Docs

169 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners